The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders

Mahoney, James J.; Garza, Richard De La; Jackson, Brian J.; Verrico, Christopher D.; Ho, Allyson; Iqbal, Tabish; Newton, Thomas F.

doi:10.1016/j.psychres.2014.05.026

Cited by 42 publications

(23 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Moreover, the results of Mahomey et al, 23 in line with the results of the current study, show that there is no significant relationship between the duration of addiction and quality of sleep. In order to explain this finding of the study, it can be said that according to previous studies, 24,25 before starting to abuse substance, addicts have a low quality of life and numerous mood and anxiety complications.…”

Section: Discussionsupporting

confidence: 90%

Predicting quality of sleep based on emotion regulation and resiliency among men with substance-related disorders in western Iran: Results from a diagnostic analysis model

Farnia

Juibari

Behrouz

et al. 2019

Clinical Epidemiology and Global Health

View full text Add to dashboard Cite

Substance abuse affects the quality of sleep and various factors can be effective as mediators of sleep quality. Therefore, the current study carried out in order to predict quality of sleep based on emotion regulation and resiliency among men with substance-related disorders (SRDs). Methods: the current study was a descriptive correlative study. The statistical population includes men with SRDs referred to maintenance treatment center (MMT) in Kermanshah City, among which 400 participants were selected based on convenient sampling. The obtained data were analyzed using descriptive statistics, chi-square test, Fisher's exact test, and the diagnostic analysis model. Results: the results of the study show that there was a significant relationship between increase in age and education level and the quality of sleep in men with SRDs (< P 0.05). However, the relationship between the duration of substance abuse and quality of sleep was not significant (> P 0.05). There was a significant relationship between emotion regulation strategies including rumination, self-blame and other-blame, catastrophizing, and acceptance and quality of sleep in men with SRDs, and the difference regarding emotion regulation and resilience between people with and without good quality of sleep was also significant (< P 0.05). Moreover, the results indicate that there is a significant relationship between resilience and the component of spirituality and the quality of sleep in men with SRDs. Finally, the two predicting variables of emotion regulation and resiliency were able to explain 69% of the variance in quality of sleep. Conclusions: using negative and non-adaptive emotion regulation strategies and low resiliency can reduce the quality of sleep among men with SRDs.

show abstract

Section: Discussionsupporting

confidence: 90%

Predicting quality of sleep based on emotion regulation and resiliency among men with substance-related disorders in western Iran: Results from a diagnostic analysis model

Farnia

Juibari

Behrouz

et al. 2019

Clinical Epidemiology and Global Health

View full text Add to dashboard Cite

show abstract

“…Sleep quality declines linearly as the number of comorbid medical conditions increases, independent of depressive status (Hayashino et al, 2010). Illicit drug use is independently associated with sleep disturbances in persons without HIV infection (Mahoney et al, 2014). Most studies focusing on sleep quality in HIV-infected individuals do not include illicit drug use among the variables recorded.…”

Section: Discussionmentioning

confidence: 99%

Factors associated with poor sleep quality among HIV-positive individuals in Mexico City

Estrada

Chiesa

Orellana

et al. 2018

View full text Add to dashboard Cite

Introduction. Sleep quality is commonly impaired in medical disorders, and the HIV-positive population is particularly vulnerable to complaint from sleep disturbances. Objective. To determine the prevalence of poor sleep quality and the factors associated with it, in a population of HIV positive Mexican out patients. Method. A cross sectional study was done. A sample of 367 HIV-positive subjects over 18 years completed a set of self-administered questionnaires: the Pittsburgh Sleep Quality Index (PSQI), the Epworth Sleepiness Scale, the Athens Insomnia Scale, and the Beck Depression Inventory. Sociodemographic and clinical data were recorded. Results. Of the respondents, 82.8% (n = 304) were male. The mean age of the patients was 36.6 (SD = 9.4) years, and the mean educational level was 12.2 (SD = 3.8) years. According to the PSQI, 58.6% (n = 215) had poor sleep quality. Poor sleep quality was more common in those who had lived longer with HIV, had started their antiretroviral treatment later, had suboptimal antiretroviral adherence, had a CD4 cell count < 200 cells/µL, reported illicit drug use, had concomitant medications, or had insomnia, sleepiness, or depressive symptoms. In multivariate analyses, poor sleep quality was associated with depressive symptoms, illicit drug use, a CD4 count < 200 cells/µL, and time elapsed since HIV diagnosis. Discussion and conclusion. Poor sleep quality is common in HIV patients. Early identification of patients with poor sleep quality through vigilance for factors associated with it might facilitate prompt treatment.

show abstract

“…These drugs are available by prescription for therapeutic use, but they may also be illegally sourced and can significantly affect sleep parameters such as sleep efficiency and sleep latency which are vital to MSLT and MWT outcome. [14][15][16][17] Amphetamines are potent stimulators of the sympathetic nervous system, 15 increasing wakefulness and sleep latency, 18,19 and are prescribed for treatment of narcolepsy. 20 They are known to decrease sleep efficiency and REM episodes.…”

Section: Discussionmentioning

confidence: 99%

“…20 They are known to decrease sleep efficiency and REM episodes. 14,18 In contrast, amphetamine withdrawal can cause complete exhaustion, decreasing sleep latency and increasing total sleep time and REM rebound. 18,21,22 Patients testing positive for amphetamines in our MSLT and MWT studies had abnormally reduced mean sleep latencies that may have been influenced by amphetamine withdrawal.…”

Section: Discussionmentioning

confidence: 99%

“…14,18 In contrast, amphetamine withdrawal can cause complete exhaustion, decreasing sleep latency and increasing total sleep time and REM rebound. 18,21,22 Patients testing positive for amphetamines in our MSLT and MWT studies had abnormally reduced mean sleep latencies that may have been influenced by amphetamine withdrawal. In addition, multiple SOREMPs observed in the MSLT patient testing positive for amphetamines may have also been a consequence of amphetamine withdrawal inducing REM rebound, although it is acknowledged that results from a single patient in our study does not provide conclusive evidence of this.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Importance of Urinary Drug Screening in the Multiple Sleep Latency Test and Maintenance of Wakefulness Test

Anniss

Young

O'Driscoll

2016

Journal of Clinical Sleep Medicine

View full text Add to dashboard Cite

Study Objectives: Multiple sleep latency testing (MSLT) and the maintenance of wakefulness test (MWT) are gold-standard objective tests of daytime sleepiness and alertness; however, there is marked variability in their interpretation and practice. This study aimed to determine the incidence of positive drug screens and their influence on MSLT, MWT, and polysomnographic variables. Methods: All patients attending Eastern Health Sleep Laboratory for MSLT or MWT over a 21-mo period were included in the study. Urinary drug screening for amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, methadone, and opiates was performed following overnight polysomnography (PSG). Demographics and PSG variables were compared. Results: Of 69 studies, MSLT (43) and MWT (26), 16% of patients had positive urinary drug screening (7 MSLT; 4 MWT). Drugs detected included amphetamines, cannabinoids, opiates, and benzodiazepines. No patient self-reported use of these medications prior to testing. No demographic, MSLT or MWT PSG data or overnight PSG data showed any statistical differences between positive and negative drug screen groups. Of seven MSLT patients testing positive for drug use, one met criteria for the diagnosis of narcolepsy and five for idiopathic hypersomnia. On MWT, three of the four drug-positive patients had a history of a motor vehicle accident and two patients were occupational drivers. Conclusions: These findings indicate drug use is present in patients attending for daytime testing of objective sleepiness and wakefulness. These data support routine urinary drug screening in all patients undergoing MSLT or MWT studies to ensure accurate interpretation in the context of illicit and prescription drug use. Keywords: excessive daytime sleepiness, hypersomnia, narcolepsy Citation: Anniss AM, Young A, O'Driscoll DM. Importance of urinary drug screening in the multiple sleep latency test and maintenance of wakefulness test.

show abstract

The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders

Cited by 42 publications

References 32 publications

Predicting quality of sleep based on emotion regulation and resiliency among men with substance-related disorders in western Iran: Results from a diagnostic analysis model

Predicting quality of sleep based on emotion regulation and resiliency among men with substance-related disorders in western Iran: Results from a diagnostic analysis model

Factors associated with poor sleep quality among HIV-positive individuals in Mexico City

Importance of Urinary Drug Screening in the Multiple Sleep Latency Test and Maintenance of Wakefulness Test

Contact Info

Product

Resources

About